- Condition: Parkinson's Disease
Interventions: Drug: rasagiline; Drug: placebo
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Blastic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; de Novo Myelodysplastic Syndromes; Noncontiguous Stage II Adult Burkitt Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Stage I Adult Burkitt Lymphoma; Stage III Adult Burkitt Lymphoma; Stage IV Adult Burkitt Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: rasburicase; Drug: allopurinol; Drug: rasburicase
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute
Recruiting - verified January 2012 - Condition: Gout
Interventions: Drug: lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Condition: Sarcopenia
Interventions: Drug: Allopurinol; Drug: Lactose tablets
Sponsors: University of Dundee; University of Dundee
Not yet recruiting - verified March 2012 - Condition: Cocaine Use Disorders
Interventions: Drug: High-dose donepezil; Drug: Low-dose donepezil; Drug: Selegiline; Drug: Placebo
Sponsors: Midwest Biomedical Research Foundation; Midwest Biomedical Research Foundation; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Condition: Parkinson's Disease
Interventions: Drug: rasagiline; Drug: placebo
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Conditions: Prehypertension; Gout; Pulse Wave Velocity; Hypertension; 24 Hour Blood Pressure
Intervention: Drug: Febuxostat
Sponsors: University of California, San Diego; University of California, San Diego; Takeda Global Research & Development Center, Inc.
Recruiting - verified November 2011 - Conditions: Sleep Disturbances; Parkinsons's Disease
Interventions: Drug: Rasagiline; Drug: Placebo
Sponsors: Dresden University of Technology; Dresden University of Technology; Teva Pharmaceutical Industries
Not yet recruiting - verified September 2011 - Condition: Bipolar Disorder I or II
Intervention: Drug: Tranylcypromine
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified September 2011 - Conditions: Hot Flashes; Menopause; Vasomotor Disturbance
Interventions: Drug: Low-dose 17-ß-estradiol; Drug: Venlafaxine XR; Drug: Placebo
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; National Institute on Aging (NIA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Complementary and Alternative Medicine (NCCAM); Office of Research on Women's Health (ORWH)
Recruiting - verified December 2011 - Condition: Parkinson Disease
Interventions: Drug: Rasagiline; Drug: Placebo
Sponsors: St. Josef Hospital Bochum; St. Josef Hospital Bochum
Not yet recruiting - verified June 2011 - Condition: Parkinson's Disease
Interventions: Drug: Rasagiline; Drug: Placebo
Sponsors: Brown University; Brown University; Teva Pharmaceuticals USA
Recruiting - verified June 2011 - Conditions: Adenocarcinoma of the Prostate; Castrate Resistant Prostate Cancer; Recurrent Prostate Cancer
Interventions: Drug: docetaxel; Procedure: prostate biopsy; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Drug: phenelzine sulfate
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Treatment Resistant Depression
Interventions: Drug: CX157; Drug: Placebo
Sponsors: CeNeRx BioPharma Inc.; CeNeRx BioPharma Inc.
Recruiting - verified October 2011 - Conditions: Parkinson Disease; Idiopathic Parkinson Disease
Interventions: Drug: Preladenant; Drug: Rasagiline; Drug: Placebo to preladenant; Drug: Placebo to rasagiline
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Parkinson's Disease
Intervention: Drug: Rasagiline
Sponsors: University of Zurich; University of Zurich; H. Lundbeck A/S
Recruiting - verified December 2011 - Conditions: Leukemia; Lymphoma
Interventions: Drug: Rasburicase; Drug: Allopurinol
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Sanofi-Aventis
Recruiting - verified April 2012 - Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet; Drug: Preladenant 5 mg tablet; Drug: Preladenant 10 mg tablet; Drug: Placebo for Preladenant; Drug: Rasagiline 1 mg capsule; Drug: Placebo for Rasagiline 1 mg capsule
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet; Drug: Preladenant 5 mg tablet; Drug: Preladenant 10 mg tablet; Drug: Rasagiline 1 mg capsule; Drug: Placebo for Rasagiline 1 mg capsule; Drug: Placebo for Preladenant
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Parkinson's Disease
Interventions: Drug: Rasagiline; Drug: Placebo
Sponsors: University of Florida; University of Florida
Recruiting - verified July 2010 - Conditions: Depressive Symptoms; Parkinson's Disease
Interventions: Drug: Rasagiline; Drug: Placebo
Sponsors: Lundbeck Italia S.p.A.; Lundbeck Italia S.p.A.; Teva Pharmaceutical Industries
Recruiting - verified March 2012 - Condition: Parkinson's Disease
Interventions: Drug: Rasagiline; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Teva Neuroscience, Inc.; H. Lundbeck A/S
Recruiting - verified February 2012 - Condition: Major Depressive Disorder
Intervention: Drug: tranylcypromine
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Conditions: Heart Failure; Elevated Serum Uric Acid
Interventions: Drug: allopurinol; Drug: sugar pill
Sponsors: Duke University; Duke University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Parkinson's Disease
Intervention: Drug: Rasagiline
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Recruiting - verified June 2011 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012
 |
Join Clinical trials for Oxidase Inhibitors |
